0001213900-17-003324.txt : 20170404
0001213900-17-003324.hdr.sgml : 20170404
20170404161640
ACCESSION NUMBER: 0001213900-17-003324
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170331
FILED AS OF DATE: 20170404
DATE AS OF CHANGE: 20170404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SCHABER CHRISTOPHER J
CENTRAL INDEX KEY: 0001068029
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 17738386
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE C-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER NAME:
FORMER CONFORMED NAME: SCHABER CHRISTOPHER
DATE OF NAME CHANGE: 19980811
4
1
f4033117schaber_soligenix.xml
OWNERSHIP DOCUMENT
X0306
4
2017-03-31
0
0000812796
SOLIGENIX, INC.
SNGX
0001068029
SCHABER CHRISTOPHER J
29 EMMONS DRIVE, SUITE C-10
PRINCETON
NJ
08540
1
1
0
0
Chairman, CEO and President
Option (Right to Buy)
2.67
2017-03-31
4
A
0
50000
0
A
2017-03-31
2027-03-30
Common Stock
50000
50000
D
The stock option vested immediately as to 12,500 shares and vests as to the remainder at a rate of 3,125 of the shares on each three (3) month anniversary of March 31, 2017.
/s/ Christopher J. Schaber
2017-04-04